Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and Their Therapeutic Potential.
Sign Up to like & getrecommendations! Published in 2022 at "Current medicinal chemistry"
DOI: 10.2174/0929867329666220825161603
Abstract: In the last decade, selective modulators of type-2 cannabinoid receptor (CB2) have become a major focus to target endocannabinoid signaling in humans. Indeed, heterogeneously expressed within our body, CB2 actively regulates several physio-pathological processes, thus… read more here.
Keywords: cb2 agonists; type cannabinoid; cb2; advances type ... See more keywords